Myalgic encephalomyelitis/chronic fatigue syndrome: From pathophysiological insights to novel therapeutic opportunities-Reference-Cited by-同舟云学术

Myalgic encephalomyelitis/chronic fatigue syndrome: From pathophysiological insights to novel therapeutic opportunities

Published:2019-10 Issue: Volume:148 Page:104450
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Morris Gerwyn,Puri Basant K.,Walker Adam J.,Maes Michael,Carvalho Andre F.,Walder Ken,Mazza Catherine,Berk Michael

Funder

NHMRC Senior Principal Research Fellowship

Publisher

Elsevier BV

Subject

Pharmacology

Reference463 articles.

1. Case definitions and diagnostic criteria for myalgic encephalomyelitis and chronic fatigue syndrome: from clinical-consensus to evidence-based case definitions;Morris;Neuro Endocrinol. Lett.,2013

2. A molecular neurobiological approach to understanding the aetiology of chronic fatigue syndrome (Myalgic encephalomyelitis or systemic exertion intolerance disease) with treatment implications;Monro;Mol. Neurobiol.,2018

3. The chronic fatigue syndrome: a comprehensive approach to its definition and study;Fukuda;Ann. Intern. Med.,1994

4. Case definitions for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): a systematic review;Brurberg;BMJ Open,2014

5. A report-chronic fatigue syndrome: guidelines for research;Sharpe;J. R. Soc. Med.,1991

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of jujube (Ziziphus jujuba mill.) fruit extracts on oxidative stress: A systematic review and meta‐analysis of rodent studies;Food Science & Nutrition;2024-05-22

2. Sleep and Long COVID—A Review and Exploration of Sleep Disturbances in Post Acute Sequelae of SARS-COV-2 (PASC) and Therapeutic Possibilities;Current Sleep Medicine Reports;2024-04-23

3. In major dysmood disorder, physiosomatic, chronic fatigue and fibromyalgia symptoms are driven by immune activation and increased immune-associated neurotoxicity;Scientific Reports;2024-03-28

4. Multi-target drugs for the treatment of cognitive impairment and fatigue in post-COVID syndrome: focus on Ginkgo biloba and Rhodiola rosea;Journal of Neural Transmission;2024-02-12

5. Infection-associated chronic disability: A transdiagnostic and translational opportunity for neuroscience;European Neuropsychopharmacology;2024-02